The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia

To explore the role of monoamines on cerebral function during specific prefrontal cognitive activation, we conducted a double-blind placebo- controlled crossover study of the effects of 0.25 mg/kg oral dextroamphetamine on regional cerebral blood flow (rCBF) as determined by 133Xe dynamic single-photon emission-computed tomography (SPECT) during performance of the Wisconsin Card Sorting Test (WCST) and a sensorimotor control task. Ten patients with chronic schizophrenia who had been stabilized for at least 6 weeks on 0.4 mg/kg haloperidol participated. Amphetamine produced a modest, nonsignificant, task- independent, global reduction in rCBF. However, the effect of amphetamine on task-dependent activation of rCBF (i.e., WCST minus control task) was striking. Whereas on placebo no significant activation of rCBF was seen during the WCST compared with the control task, on amphetamine significant activation of the left dorsolateral prefrontal cortex (DLPFC) occurred (p = 0.0006). Both the mean number of correct responses and the mean conceptual level increased (p less than 0.05) with amphetamine relative to placebo. In addition, with amphetamine, but not with placebo, a significant correlation (p = - 0.71; p less than 0.05) emerged between activation of DLPFC rCBF and performance of the WCST task. These findings are consistent with animal models in which mesocortical catecholaminergic activity modulates and enhances the signal-to-noise ratio of evoked cortical activity.

[1]  R. Thisted,et al.  Spreading depression increases immunohistochemical staining of glial fibrillary acidic protein , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[2]  J. Barker,et al.  The site for initiation of action potential discharge over the somatodendritic axis of rat hippocampal CA1 pyramidal neurons , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[3]  T Okada,et al.  Release of endogenous excitatory amino acids from ON-type bipolar cells isolated from the goldfish retina , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[4]  L J Regan,et al.  Voltage-dependent calcium currents in Purkinje cells from rat cerebellar vermis , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[5]  G. Damsma,et al.  Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[6]  T. Goldberg,et al.  Cognitive and behavioral effects of the coadministration of dextroamphetamine and haloperidol in schizophrenia. , 1991, The American journal of psychiatry.

[7]  D. Weinberger,et al.  Lateralisation of cortical function during cognitive tasks: regional cerebral blood flow studies of normal individuals and patients with schizophrenia. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[8]  D. Segal,et al.  Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[9]  Isak Prohovnik,et al.  Dissociated effects of amphetamine on arousal and cortical blood flow in humans , 1989, Biological Psychiatry.

[10]  L. Bigelow,et al.  The Psychiatric Symptom Assessment Scale (PSAS). , 1989, Psychopharmacology bulletin.

[11]  D. Weinberger,et al.  The effect of apomorphine on regional cerebral blood flow in schizophrenia. , 1989, The Journal of neuropsychiatry and clinical neurosciences.

[12]  Bigelow Lb,et al.  The Psychiatric Symptom Assessment Scale (PSAS). , 1989 .

[13]  D. Weinberger,et al.  Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism. , 1988, Archives of general psychiatry.

[14]  D. Weinberger,et al.  Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. IV. Further evidence for regional and behavioral specificity. , 1988, Archives of general psychiatry.

[15]  D. Weinberger,et al.  Speculation on the meaning of cerebral metabolic hypofrontality in schizophrenia. , 1988, Schizophrenia bulletin.

[16]  S. Iversen,et al.  Handbook of Psychopharmacology , 1988, Springer US.

[17]  T. Sawaguchi.  Catecholamine sensitivities of neurons related to a visual reaction time task in the monkey prefrontal cortex. , 1987, Journal of Neurophysiology.

[18]  June Corwin,et al.  Early pharmacokinetics and clinical effects of oral d-amphetamine in normal subjects , 1987, Biological Psychiatry.

[19]  J. Krieglstein,et al.  Alterations in regional energy metabolism in rat brain produced by small and by large doses of apomorphine: possible relations to autoreceptors. , 1987, European journal of pharmacology.

[20]  J. Harvey.  Behavioral pharmacology of central nervous system stimulants , 1987, Neuropharmacology.

[21]  C. H. Vanderwolf.  Suppression of serotonin-dependent cerebral activation: a possible mechanism of action of some psychotomimetic drugs , 1987, Brain Research.

[22]  L. DeLisi,et al.  Dysfunction in a prefrontal substrate of sustained attention in schizophrenia. , 1987, Life sciences.

[23]  R. Chiarello,et al.  The use of psychostimulants in general psychiatry. A reconsideration. , 1987, Archives of general psychiatry.

[24]  R. Glennon,et al.  Methcathinone: A new and potent amphetamine-like agent , 1987, Pharmacology Biochemistry and Behavior.

[25]  N. Volkow,et al.  Phenomenological correlates of metabolic activity in 18 patients with chronic schizophrenia. , 1987, The American journal of psychiatry.

[26]  M. Arné-Bès,et al.  Reversibility of Hemodynamic Hypofrontality in Schizophrenia , 1987, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[27]  T. Itakura,et al.  The distribution of adrenergic receptors in cerebral blood vessels: an autoradiographic study , 1986, Brain Research.

[28]  William H. Wilson,et al.  Determinants of resting regional cerebral blood flow in normal subjects , 1986, Biological Psychiatry.

[29]  M. Savasta,et al.  Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390 , 1986, Brain Research.

[30]  D. Weinberger,et al.  Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. , 1986, Archives of general psychiatry.

[31]  D. Weinberger,et al.  Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. II. Role of neuroleptic treatment, attention, and mental effort. , 1986, Archives of general psychiatry.

[32]  C. Braestrup,et al.  Some atypical neuroleptics inhibit [3H]SCH 23390 binding in vivo. , 1986, European journal of pharmacology.

[33]  J. Glowinski,et al.  Contribution of Noradrenergic Neurons to the Regulation of Dopaminergic (D1) Receptor Denervation Supersensitivity in Rat Prefrontal Cortex , 1986, Journal of neurochemistry.

[34]  Cerebral blood flow in schizophrenic adolescents. , 1986, The American journal of psychiatry.

[35]  L. Opler,et al.  L-DOPA in the Treatment of Negative Schizophrenic Symptoms: A Single-Subject Experimental Study , 1986, International journal of psychiatry in medicine.

[36]  John D. McKenzie,et al.  Number Cruncher Statistical Systems (NCSS) , 1985 .

[37]  O B Paulson,et al.  Regional Cerebral Blood Flow Assessed by 133Xe Inhalation and Emission Tomography: Normal Values , 1985, Journal of computer assisted tomography.

[38]  L. Opler,et al.  Combined mesoridazine and amantadine treatment in refractory schizophrenics , 1985 .

[39]  B. Siesjö,et al.  Cerebral circulation and metabolism. , 1984, Journal of neurosurgery.

[40]  B. Jacobs,et al.  Physiological and Behavioral Analysis of Raphe Unit Activity , 1984 .

[41]  L. Sokoloff.  Modeling metabolic processes in the brain in vivo , 1984, Annals of neurology.

[42]  D. Stuss,et al.  The involvement of orbitofrontal cerebrum in cognitive tasks , 1983, Neuropsychologia.

[43]  M. Palmer,et al.  Effects of dopamine on spontaneous and evoked activity of caudate neurons , 1983, Neuropharmacology.

[44]  I. Creese.  Stimulants, neurochemical, behavioral, and clinical perspectives , 1983 .

[45]  B. Milner,et al.  Deficits on subject-ordered tasks after frontal- and temporal-lobe lesions in man , 1982, Neuropsychologia.

[46]  P. Valdiguie,et al.  Cerebral Circulatory Effects of a Dopaminergic Agonist (Apomorphine) in the Dog , 1982, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[47]  M. Arné-Bès,et al.  Effects of a Dopaminergic Agonist (Piribedil) on Cerebral Blood Flow in Man , 1982, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[48]  J. Marín,et al.  Nerve endings and pharmacological receptors in cerebral vessels. , 1982, General pharmacology.

[49]  N. Lassen,et al.  A Method for Calculating Regional Cerebral Blood Flow from Emission Computed Tomography of Inert Gas Concentrations , 1981, Journal of computer assisted tomography.

[50]  J. Webster,et al.  Frontal Lobe Lesions and Behavior* , 1981, Southern medical journal.

[51]  N. Lassen,et al.  A single photon dynamic computer assisted tomograph (DCAT) for imaging brain function in multiple cross sections. , 1980, Journal of computer assisted tomography.

[52]  H. E. Rosvold,et al.  Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. , 1979, Science.

[53]  Arthur E. Rosenbaum,et al.  An Atlas of the Human Brain for Computerized Tomography , 1979 .

[54]  I Kanno,et al.  Two Methods for Calculating Regional Cerebral Blood Flow from Emission Computed Tomography of Inert Gas Concentrations , 1979, Journal of computer assisted tomography.

[55]  L. Sokoloff,et al.  EFFECTS OF d‐ AND l‐AMPHETAMINE ON LOCAL CEREBRAL GLUCOSE UTILIZATION IN THE CONSCIOUS RAT 1 , 1979, Journal of neurochemistry.

[56]  S. Scarone,et al.  Catecholaminergic drugs in chronic schizophrenia. , 1979, Neuropsychobiology.

[57]  L. Mchenry,et al.  Xenon-133 Inhalation Method for Regional Cerebral Blood Flow Measurements: Normal Values and Test-Retest Results , 1978, Stroke.

[58]  B. Siesjö,et al.  Circulatory and metabolic effects in the brain induced by amphetamine sulphate. , 1978, Acta physiologica Scandinavica.

[59]  K. E. Moore,et al.  Amphetamines: Biochemical and Behavioral Actions in Animals , 1978 .

[60]  A. Hirano,et al.  AN ATLAS OF THE HUMAN BRAIN FOR COMPUTERIZED TOMOGRAPHY. , 1978 .

[61]  S. Antelman,et al.  Norepinephrine-dopamine interactions and behavior. , 1977, Science.

[62]  J. Mcculloch,et al.  Cerebral circulatory and metabolism changes following amphetamine administration , 1977, Brain Research.

[63]  C. Ogura,et al.  Clinical effect of L-dopa on schizophrenia. , 1976, Current therapeutic research, clinical and experimental.

[64]  M E Raichle,et al.  Correlation Between Regional Cerebral Blood Flow and Oxidative Metabolism: In Vivo Studies in Man , 1976 .

[65]  B. Siesjö,et al.  Excessive increase in oxygen uptake and blood flow in the brain during amphetamine intoxication. , 1976, Acta Physiologica Scandinavica.

[66]  S. Snyder,et al.  The dopamine hypothesis of schizophrenia: focus on the dopamine receptor. , 1976, The American journal of psychiatry.

[67]  F. Buchanan,et al.  Double Blind Trial of L-Dopa in Chronic Schizophrenia* , 1975, The Australian and New Zealand journal of psychiatry.

[68]  K. Inanaga,et al.  Double‐Blind Controlled Study of L‐Dopa Therapy in Schizophrenia , 1975, Folia psychiatrica et neurologica japonica.

[69]  Christer Carlsson,et al.  Influence of Amphetamine Sulphate on Cerebral Blood Flow and Metabolism , 1975 .

[70]  Robert Freedman,et al.  Effects of putative neurotransmitters on neuronal activity in monkey auditory cortex , 1975, Brain Research.

[71]  Martin Reivich,et al.  Cerebral Circulation and Metabolism , 1975, Springer Berlin Heidelberg.

[72]  S. Nahorski,et al.  IN VIVO EFFECTS OF AMPHETAMINE ON METABOLITES AND METABOLIC RATE IN BRAIN , 1973, Journal of neurochemistry.

[73]  K. Inanaga,et al.  Effect of L‐Dopa in Schizophrenia , 1972, Folia psychiatrica et neurologica japonica.

[74]  B. Angrist,et al.  The phenomenology of experimentally induced amphetamine psychosis--preliminary observations. , 1970, Biological psychiatry.

[75]  T. Hökfelt,et al.  Evidence for dopamine receptor stimulation by apomorphine , 1967, The Journal of pharmacy and pharmacology.

[76]  E. Ellinwood.  Amphetamine psychosis : description of the individuals and processes , 1967 .

[77]  E. Ellinwood.  AMPHETAMINE PSYCHOSIS: I. DESCRIPTION OF THE INDIVIDUALS AND PROCESS , 1967 .

[78]  B. Milner.  Effects of Different Brain Lesions on Card Sorting: The Role of the Frontal Lobes , 1963 .

[79]  J. Overall,et al.  The Brief Psychiatric Rating Scale , 1962 .

[80]  L. Hollister,et al.  COMBINED DRUG THERAPY OF CHRONIC SCHIZOPHRENICS , 1961 .

[81]  J. Mcfie,et al.  The relation of laterality of lesion to performance on Weigl's sorting test. , 1952, The Journal of mental science.

[82]  H. Shenkin,et al.  Effects of various drugs upon cerebral circulation and metabolism of man. , 1951, Journal of applied physiology.

[83]  G. W. Liddle,et al.  Influence of amphetamine sulfate on cerebral metabolism and blood flow in man. , 1949, Journal of the American Pharmaceutical Association. American Pharmaceutical Association.

[84]  D. A. Grant,et al.  A behavioral analysis of degree of reinforcement and ease of shifting to new responses in a Weigl-type card-sorting problem. , 1948, Journal of experimental psychology.